News
21-09-2023
First iVAC 2L case in New Zealand
🚀A new milestone in New Zealand 🚀 We are thrilled to announce the first protected High-Risk PCI with the successful support of iVAC 2L performed by Dr. Sanjeevan…
28-08-2023
Launch iVAC 2L in Jordan
🚀A new milestone in Jordan 🚀 We are thrilled to announce the first protected High-Risk PCI with the successful support of iVAC 2L performed by Dr. Amer Al…
16-08-2023
Saudi Arabia Product Registration iVAC 2L
🌍 Exciting news! Another important milestone for expanding the market in the Middle East. We are thrilled to announce the achievement of product registration for iVAC 2L in…
05-07-2023
Mexico Product Registration iVAC 2L
🌍 PulseCath is expanding their global footprint Exciting news! We are thrilled to announce the achievement of product registration for iVAC 2L in Mexico. We are looking forward…
15-06-2023
SCC2023, The 24th South China International Congress of Cardiology in Gangzhou, China, June 2023
Together with our strategic partner Huadong Medicine we were attending SCC2023, The 24th South China International Congress of Cardiology in Gangzhou last week. Many participants and interest at…
30-05-2023
Pre-launch in Saudi Arabia
Exciting news: in Saudi Arabia the first pre-launch training activities started this month. We are looking forward to the product registration and the launch of iVAC 2L –…
26-04-2023
Poland Warsaw Course on Cardiovascular Interventions
WCCI, or Warsaw Course on Cardiovascular Interventions , is one of the most important conferences organized in Warsaw under the auspices of the Association of Cardiovascular Interventions (AISN)…
08-03-2023
Announcement Center of Excellence in Dubai
We are proud to announce the AL QASSIMI HOSPITAL, Sharjah, Dr Arif Al Nooryani, Chief Executive Officer & Head of Cardiac Centre for being appointed as Center of…
16-02-2023
“30 Most Valuable Brands of the Year 2022”
PulseCath BV is listed by Silicon Review under “30 Most Valuable Brands of the Year 2022″. We are really honoured and proud to be part of this. Thank…
09-02-2023
Germany NUB status 1 reimbursement iVAC 2L
Great achievement in Germany: NUB status 1 reimbursement for iVAC 2L in Germany again, with a record of #300 hospitals! Especially during these uncertain times, this is another significant support…
